Taigen Biopharmaceuticals Holdings Ltd (4157) — Working Capital to Net Assets Ratio
Taigen Biopharmaceuticals Holdings Ltd (4157) has a Working Capital to Net Assets ratio of 96.5% as of December 2025. Working capital of NT$1.04 Billion (current assets of NT$1.12 Billion minus current liabilities of NT$83.11 Million) is measured against net assets of NT$1.07 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 4157 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Taigen Biopharmaceuticals Holdings Ltd Working Capital to Net Assets (2010–2025)
This chart shows how Taigen Biopharmaceuticals Holdings Ltd's Working Capital to Net Assets ratio has evolved across 16 annual periods from 2010 to 2025. As of December 2025, the ratio stands at 96.5%, reflecting working capital of NT$1.04 Billion against net assets of NT$1.07 Billion TWD. See how many days can Taigen Biopharmaceuticals Holdings Ltd fund operations to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Taigen Biopharmaceuticals Holdings Ltd (2010–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Taigen Biopharmaceuticals Holdings Ltd from 2010 to 2025, covering 16 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 4157 stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 96.5% | NT$1.04 Billion | NT$1.07 Billion | NT$1.12 Billion | NT$83.11 Million | ▲ +0.4 pp |
| 2024 | 96.1% | NT$1.04 Billion | NT$1.08 Billion | NT$1.09 Billion | NT$46.08 Million | ▲ +1.1 pp |
| 2023 | 95.0% | NT$1.06 Billion | NT$1.12 Billion | NT$1.11 Billion | NT$47.89 Million | ▲ +2.4 pp |
| 2022 | 92.6% | NT$897.91 Million | NT$970.03 Million | NT$949.24 Million | NT$51.32 Million | ▲ +1.5 pp |
| 2021 | 91.1% | NT$1.14 Billion | NT$1.25 Billion | NT$1.23 Billion | NT$89.88 Million | ▲ +24.0 pp |
| 2020 | 67.1% | NT$296.69 Million | NT$442.18 Million | NT$391.60 Million | NT$94.91 Million | ▼ -8.3 pp |
| 2019 | 75.4% | NT$614.51 Million | NT$815.18 Million | NT$703.82 Million | NT$89.31 Million | ▲ +5.9 pp |
| 2018 | 69.5% | NT$759.75 Million | NT$1.09 Billion | NT$825.58 Million | NT$65.83 Million | ▼ -0.8 pp |
| 2017 | 70.3% | NT$1.00 Billion | NT$1.42 Billion | NT$1.07 Billion | NT$69.72 Million | ▼ -23.9 pp |
| 2016 | 94.2% | NT$636.30 Million | NT$675.62 Million | NT$757.37 Million | NT$121.06 Million | ▼ -2.3 pp |
| 2015 | 96.5% | NT$426.26 Million | NT$441.60 Million | NT$559.75 Million | NT$133.48 Million | ▼ -7.7 pp |
| 2014 | 104.2% | NT$888.23 Million | NT$852.14 Million | NT$1.04 Billion | NT$147.99 Million | ▼ -51.7 pp |
| 2013 | 155.9% | NT$239.72 Million | NT$153.77 Million | NT$429.23 Million | NT$189.51 Million | ▲ +23.0 pp |
| 2012 | 132.9% | NT$495.48 Million | NT$372.80 Million | NT$678.30 Million | NT$182.82 Million | ▲ +41.6 pp |
| 2011 | 91.3% | NT$468.81 Million | NT$513.21 Million | NT$554.89 Million | NT$86.08 Million | ▼ -12.8 pp |
| 2010 | 104.2% | NT$-4.47 Billion | NT$-4.29 Billion | NT$923.10 Million | NT$5.39 Billion | — |